SNMMI

Radiotracer Identifies Metastatic Prostate Cancer Regardless of Anatomic Region

June 17, 2021

Recently approved PMSA-targeted radiotracer can pinpoint biochemical recurrent prostate cancer in men with unhelpful standard imaging.

PET Imaging Shows Increased Dementia Risk with Lipophilic Statins

June 16, 2021

Patients with mild cognitive impairment who take lipophilic statins have a more than doubled risk of progressing to dementia.

Novel PET Tracer Capable of Predicting Abdominal Aortic Aneurysm Rupture

June 16, 2021

Tested so far in animal models, this tracer could further the development of treatments for this life-threatening disease for which there are currently no therapies.

PET Imaging Reveals Efficacy of Novel Cancer Treatment

June 14, 2021

New therapy uses light from decaying radiopharmaceuticals to attack cancer cells from inside the body.

PET Technique Harnesses Head Movement to Improve Resolution

June 13, 2021

Using an external tracking device can lead to super-resolution that can potentially improve neurological disorder detection.

PET Radiotracer Can Detect, Assess Lung Fibrosis

June 12, 2021

Use enables direct imaging of disease process.

SPECT + Deep Learning = Accurate Major Cardiac Event Prediction

June 11, 2021

Using advanced artificial intelligence can give patients a personalized assessment of their risk for significant events, such as heart attack or death.

PET Scan of Super-Agers Crowned SNMMI Image of the Year

July 17, 2020

Images reveal older adults with above-average cognitive abilities have a resistance to tau and amyloid proteins.

PSMA PET/CT Prompts Prostate Cancer Management Changes in 66 Percent of Patients With Recurrent Disease

July 16, 2020

Using 18F-DCPyL PSMA PET/CT can pinpoint more cancers in men who have biochemical failure with initial treatment.

New MRI Approach Helps Assess Knee Osteoarthritis Progression

July 15, 2020

Using PET/MRI 18F NaF offers new functional measure for assessing degeneration of knee joints.